Empecid

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Empecid

Property Description
Active Ingredient Clotrimazole (Clotrimazol)
Pharmacological Class Azole Antifungal / Imidazole Derivative
Origin Synthetic chemical compound
Common Forms Cream, Spray, Vaginal Tablets/Pessaries
General Purpose Antimycotic action against fungi

The Identity of Empecid (Clotrimazole)

Empecid is a commercial preparation containing the synthetic, single-ingredient product Clotrimazole (Clotrimazol). This compound is classified as an antifungal agent and belongs to the imidazole derivative group within the broader azole antifungal pharmacological class. Its formulation as Empecid, often marketed by Bayer AG, is frequently available Over-the-Counter (OTC) in various regions, facilitating accessible treatment for common superficial infections.

As an antimycotic agent, the use of Clotrimazole is supported by extensive pharmacological studies recognizing its established efficacy against the pathogenic fungi and yeasts responsible for common conditions like athlete’s foot. The core composition is a single-ingredient product, featuring the active ingredient combined with pharmaceutical bases suitable for targeted delivery. Clotrimazole is recognized for its role in global public health and the treatment of essential medical conditions.

Forms and General Antimycotic Purpose

Clotrimazole is utilized in several different dosage form(s) to suit various routes of administration, ensuring precise delivery to the site of infection. These include topical preparations like cream and spray for the skin, and specialized vaginal preparations such as tablets (pessaries) for internal use. The existence of multiple forms, such as Empecid Gyno for gynecological use, illustrates a focused approach to specific patient groups and delivery methods.

Its general purpose is to achieve an effective antimycotic function by destroying the causative fungal organisms. A broad consensus across clinical guidelines confirms that azole antifungals are a primary choice for these types of fungal overgrowth. The medication targets the structural integrity of the fungal cell, which is necessary to resolve the underlying fungal infections and return the affected area to a healthy state.

What side effects are possible with Empecid?

Possible Side Effects and Safety Information

The safety profile for Clotrimazole, the active ingredient in Empecid, is documented in official regulatory sources, with adverse reactions organized by frequency and affected physiological system.


Documented Adverse Reactions and Frequency

The majority of documented reactions are localized and classified by frequency based on clinical data:

  • Common Reactions (May affect up to 1 in 10 people): These events occur typically at the application site. They include a burning sensation, stinging, local irritation, pruritus (itching), and erythema (redness).
  • Serious Adverse Reactions (Frequency Not Known): Although rare, systemic allergic reactions (hypersensitivity) are officially documented. Severe manifestations may involve dyspnoea (difficulty breathing), hypotension (low blood pressure), and syncope (fainting), which are classified as serious in regulatory texts.

System-Organ Classification and Limitations

Adverse events are grouped into System-Organ Classes (SOCs) for clarity:

System-Organ Class Associated Effects (Examples)
Skin and Subcutaneous Tissue Disorders Rash, oedema (swelling), blisters, and exfoliation.
Immune System Disorders Hypersensitivity and allergic responses.
General Disorders and Administration Site Conditions Localized pain and irritation.

Safety limitations include a contraindication against use in individuals with a known hypersensitivity to Clotrimazole or any formulation excipients. Furthermore, official safety notes address use during pregnancy (caution advised in the first trimester) and state that excretion in breast milk during lactation is not known, reflecting minimal systemic absorption.

Overdose and Emergency Response

Overdose and when to seek help

Regulatory documentation indicates that acute overdosage with the intended topical or vaginal application of Clotrimazole is unlikely and is not expected to lead to a life-threatening situation. The risk profile is structured to address accidental exposure and specific drug interaction scenarios.

Symptoms of overdose, such as Nausea and Vomiting, are documented only in the context of accidental oral ingestion of the product. Official instructions mandate that immediate medical attention must be sought, or a Poison Control center contacted, if the medicine is swallowed. Emergency services should be called immediately if the affected person has collapsed or is not breathing, as required by government guidance.

There is no specific antidote known for Clotrimazole overdose. Management in the case of accidental ingestion is symptomatic and supportive, with procedural steps like gastric lavage considered only if clinical symptoms become apparent. Furthermore, a specific regulatory requirement exists for patients who are co-administering vaginal Clotrimazole with the oral immunosuppressants tacrolimus or sirolimus. These individuals must be thoroughly monitored for signs and symptoms of overdosage of the immunosuppressant, as explicitly documented in regulatory labeling.

Therapeutic Uses of Empecid

What Empecid Treats: Main Uses and Benefits

Empecid is commonly used in areas where short-term symptom management is appropriate for conditions involving superficial fungal and yeast infections. It is applied in clinical settings that involve acute or unstable symptom patterns, often used during phases when symptoms become more noticeable and may interfere with daily functioning.

The medication is considered relevant for easing symptoms in conditions presenting with systemic or localized discomfort, such as tinea infections and vaginal yeast. The medicine is commonly used to help with conditions caused by a fungus or yeast, and is relevant for easing symptoms related to inflammatory or irritative states.

The medicine is used for common conditions including athlete’s foot, ringworm, and vaginal thrush. It assists in addressing symptom clusters that may become intense or disruptive, such as persistent itching and the burning sensation associated with fungal overgrowth, supporting general well-being during symptomatic phases.

Quick Fact

Quick Fact: Supports relief from Symptomatic Discomfort

Eligibility and Restrictions for Use

Who can and cannot use Empecid?

Use of Empecid is strictly defined by regulatory eligibility criteria documented by government health authorities. The medicine is contraindicated for any individual with a known hypersensitivity or allergy to the active ingredient, Clotrimazole, or any of its excipients.

Age-Related Eligibility Rules

The official labeling sets specific restrictions across life stages. Topical formulations are not recommended for children under 2 years of age without a doctor's guidance. Vaginal formulations are not for use in females under 16 years, and older adults, specifically women aged 60 and over, should seek medical advice prior to using vaginal preparations.

Pregnancy and Conditional Use Restrictions

Eligibility is restricted by physiological status. Use during the first trimester of pregnancy is restricted, only proceeding if clearly indicated by a physician. In later stages, it may be used, but with the specific condition that the vaginal tablet is inserted without an applicator. The medicine may be used while breastfeeding due to minimal systemic absorption.

For over-the-counter use, patients must seek medical advice if they have symptoms like abnormal vaginal bleeding, a history of sexually transmitted disease, or more than two infections in six months. Furthermore, the product is not suitable for use in the eyes, on the nails, or on the scalp.

What should I know about interactions with other medicines?

The interaction profile for Clotrimazole is defined by both local substance compatibility and potential systemic metabolic effects. A critical local interaction involves material damage caused by intravaginal preparations to latex and rubber barrier contraceptives, including condoms, diaphragms, and cervical caps, which reduces their effectiveness and can result in contraceptive failure. For this reason, regulatory restrictions advise the use of alternative contraceptive methods during treatment and for at least five days afterward.

Furthermore, co-administration of other intravaginal products, such as tampons, douches, or spermicides, is subject to specific constraints and should be avoided during the course of treatment.

Clotrimazole is documented as an inhibitor of the CYP3A4 enzyme. While minimal absorption from topical forms generally limits systemic interaction, this metabolic effect becomes clinically significant if systemic exposure occurs. Co-administration with immunosuppressants like Tacrolimus and Sirolimus is known to increase their plasma concentrations and reduce their clearance, potentially leading to supratherapeutic blood levels. Due to the hepatic metabolism involved, the regulatory profile includes a note requiring monitoring of liver function tests in patients with pre-existing hepatic impairment if systemic exposure is a factor.

Mechanism of Action

Empecid (Clotrimazole) exerts its action by directly targeting and inhibiting a specific fungal enzyme called lanosterol 14-alpha-demethylase (CYP51). This cytochrome P450 oxidase is a vital part of the fungal cell's metabolic cascade responsible for synthesizing ergosterol, the fundamental structural component of the cell membrane. By binding to and functionally disabling this enzyme, the drug immediately halts ergosterol production and initiates a severe metabolic disruption within the pathogen.

This ergosterol depletion and the concurrent accumulation of toxic sterol intermediates cause the fungal cell membrane to lose its essential structural integrity and fluidity. The resulting cellular compromise leads to increased membrane permeability, a mechanistic event that causes the leakage of essential internal components from the fungal cell. This targeted structural damage produces the definitive antimycotic physiological effect (destruction or growth inhibition) upon contact with the pathogen in the localized tissue environment.

The mechanism is highly specific to the fungal enzyme; however, this action is constrained to the localized area and is functionally limited in dense tissues or deep infections where achieving the necessary high drug concentration is physiologically challenging.

Dosage and Administration Information

How to Use Empecid: Administration Guidelines

The use of Empecid (Clotrimazole) is defined by standards that prescribe specific routes, dosages, and administration techniques for its various forms. These instructions ensure consistent application as outlined in prescribing information.


Administration Scope

Property Instruction
Route of administration Topical (Dermal) for skin infections; Intravaginal for vulvovaginal candidiasis; Oral/Transmucosal (lozenge) for oropharyngeal candidiasis.
Dosing schedule Topical: Apply a thin layer or a 0.5 cm strip of cream. Intravaginal: One full applicatorful of cream or one tablet/pessary (100 mg to 500 mg dose). Oral Lozenge: 10 mg per dose.
Frequency and timing Topical: Two to three times daily. Intravaginal: Once daily, preferably at bedtime. Oral Lozenge: Five times daily for treatment.
Course Duration Topical: Typically 2 to 4 weeks. Intravaginal: Courses range from a single 500 mg application up to 7 consecutive days for lower-strength regimens.
Age-group rules Topical/Intravaginal: Approved for adults and children 12 years of age and older for self-medication. Oral Lozenge: Approved for children 3 years of age and older.

Special Procedural Conditions

Standard handling constraints are essential for proper use. Treatment should not be performed during the menstrual period. When using intravaginally during pregnancy, the dose should be inserted without using an applicator. For the oral lozenge form, the product must be allowed to dissolve slowly in the mouth over approximately 30 minutes; it should not be chewed or swallowed whole. The full prescribed course must always be completed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Empecid (Clotrimazole)


Evidence for Use in Common Skin Fungal Infections (Tinea)

Clotrimazole was studied for its application in common skin fungal infections, which include conditions such as Athlete’s Foot (Tinea Pedis), Ringworm (Tinea Corporis), and Jock Itch (Tinea Cruris). The research base includes Randomized Controlled Trials (RCTs) and studies examining differences between treatments. These trials research examined outcomes related to physical discomfort and the resolution of visible symptoms (known as clinical cure), alongside laboratory evidence of fungal clearance (mycological cure). Studies was observed in adults and adolescents who had confirmed infections.

In these trials, the findings describe patterns observed where treatment was associated with the measured clearance of the fungi from the skin, as verified by lab tests in the short term. Comparative evidence describes measurements of the intended outcome when compared to those reported for other established topical applications.


Evidence for Use in Vaginal Yeast Infections (VVC)

The evidence for the use of topical Clotrimazole in vulvovaginal candidiasis (VVC) was evaluated in numerous RCTs and Systematic Reviews. The studies monitored both clinical endpoints—such as the tracked changes in symptoms linked to inflammatory or irritative states like itching and burning—and the documented status of the yeast from the affected area.

Trial results documented measurable mycological clearance rates observed shortly after the conclusion of the treatment course in observed populations with uncomplicated infections. This body of evidence contributes to the broader evidence landscape regarding short-term approaches for uncomplicated vaginal yeast infections.


What Remains Uncertain in the Research Landscape

While the evidence base is extensive, particularly for initial application response, key limitations are often cited in scientific reviews. For all indications, follow-up durations were limited, leaving the long-term effects are not fully established. Research has explored the use of the medicine in specific populations, such as pregnant women, and the medicine has an authorized indication for children for certain skin conditions; however, data for certain groups remain insufficient, as these individuals are frequently excluded from standard clinical trials.

Key Studies & References

  1. Clotrimazole - StatPearls (Clinical Indications and Pharmacology Overview)
  2. Public Assessment Report Scientific discussion Canesten Gyno 1 soft capsule, 500 mg vaginal capsules (clotrimazole) (EMA/NL Regulatory Review)
  3. Clotrimazole (WHO Essential Medicines List Status)

Frequently Asked Questions (FAQ)

Common questions about Empecid (FAQ)


Q: What is the main reason a doctor might prescribe Empecid?

A: Official documents define Empecid as an antifungal agent. Its approved uses typically include treatment for certain fungal infections of the skin, such as ringworm and athlete's foot, as well as vulvovaginal candidiasis (yeast infections).


Q: Can Empecid affect the results of lab tests?

A: Official warnings primarily relate to the need for monitoring liver function tests in individuals who have pre-existing liver issues. This is noted especially when using the oral formulations where some systemic exposure may occur.


Q: What should I know about Empecid and driving or operating machinery?

A: According to official product information, the topical and vaginal preparations of Empecid are described as having no or negligible influence on the ability to drive or operate machinery. This statement is based on the drug's limited absorption into the body when used locally.


Q: Is Empecid considered a high-risk medication in official documents?

A: Regulatory classifications indicate that the medicine is not listed as a controlled substance by US bodies. Furthermore, its inclusion on the WHO Model List of Essential Medicines reflects its recognized role in global public health systems.


Q: Can Empecid be taken at the same time as certain vitamin supplements?

A: Authoritative summaries often state there is insufficient information on interactions with dietary or vitamin supplements. This is because these products are generally not tested under the same strict regulatory framework as authorized prescription and over-the-counter drugs.


Q: Do regulatory bodies classify Empecid as a controlled substance?

A: Regulatory labeling in the United States consistently indicates that the drug is not classified as a controlled substance, listing its DEA Schedule as None.


Q: What is the difference between how Empecid works and how its competitors work?

A: Official documents classify the drug as an Azole Antifungal. Its mechanism involves disrupting the production of ergosterol, which is a unique structural component of the fungal cell membrane, leading to a compromise of its structure and function. This mechanism is chemically distinct from other classes of antifungal agents.


Q: Is Empecid widely used outside of the country where it was first approved?

A: The medicine is included on the WHO Model List of Essential Medicines, which is a list of medications considered necessary for a basic health care system. This inclusion signifies that the drug is recognized as essential for public health systems globally.


Q: How long does the effect of a typical dose of Empecid usually last?

A: The duration of the intended effect can be inferred from the product’s official administration schedule, which is designed to maintain the necessary drug concentration in the localized area of infection.


Q: Is there a known general interaction between Empecid and alcohol?

A: Official warnings related to liver function are primarily for the oral forms of the medicine. Official sources indicate that liver function is subject to monitoring for the oral form in certain patients, because alcohol consumption is known to affect liver function.


Q: What is the general safety profile of Empecid in official summaries?

A: Official summaries generally characterize the safety profile by noting that most adverse reactions are localized to the application site, such as burning or irritation. Serious systemic events, such as allergic reactions, are documented as rare occurrences.


Q: Are there any widely discussed benefits of Empecid that are not officially approved uses?

A: Regulatory documentation strictly limits the discussion of the drug’s benefits to the officially approved indications. The official label does not contain information or recommendations concerning off-label or non-approved uses.


Q: Does taking Empecid require any special monitoring by healthcare professionals?

A: Official documentation states that monitoring is required for patients with pre-existing hepatic impairment (liver conditions) or those taking certain immunosuppressant medications, such as Tacrolimus or Sirolimus. This monitoring is necessary to track the drug's effect on liver enzyme levels.


Q: Is Empecid designed to be used as an immediate relief or a long-term treatment?

A: The prescribed duration of use in official documents ranges from a single application up to a 4-week course for certain conditions. This range indicates that the drug is designed for short-course treatment regimens, rather than indefinite long-term use.


Q: Do studies suggest any specific time of day is better for taking Empecid?

A: Official instructions define the timing for intravaginal preparations based on the need to assist with the retention of the product at the site of infection and maximize its intended local effect.


Q: Does Empecid have any known impact on fertility (descriptive only)?

A: Some official summaries state that no human studies on fertility have been performed. Animal studies that were conducted have demonstrated no effects of the drug on fertility.


Q: Can Empecid affect blood pressure readings?

A: Systemic allergic reactions, which are documented as a rare but serious adverse event, may include symptoms such as hypotension (low blood pressure). This type of serious reaction would be reflected in a blood pressure reading.


Q: What is meant by the 'mechanism of action' for Empecid in simple terms?

A: The mechanism of action describes how the drug works. Official texts explain that the drug works by compromising the integrity of the fungal cell membrane, which limits the growth and reproduction of the fungus. This occurs by disrupting the cell’s production of its primary structural material, ergosterol.


Q: Is Empecid a prescription-only medicine in most countries?

A: Empecid is often available for purchase Over-the-Counter (OTC) in many countries for the treatment of common superficial infections. However, prescription-only versions or higher-strength formulations may also exist.


Q: What are the general precautions related to using Empecid with herbal remedies?

A: Regulatory reviews often state there is insufficient information available regarding interactions with herbal remedies and other non-regulated products. This is because these products are not typically tested for interactions under the same clinical standards as official medications.


Q: Is the term 'off-label use' relevant to discussions about Empecid?

A: Regulatory documentation strictly limits the discussion of the drug’s uses to the officially approved indications. The document intentionally avoids any mention or suggestion of non-approved uses, which fall under the category of off-label use.


Q: What is the difference between a common side effect and a serious adverse reaction for Empecid?

A: Official documents describe common reactions as typically localized to the application site, such as mild irritation or burning. Serious reactions are defined as rare systemic events that involve severe symptoms, such as severe allergic reactions or difficulty breathing.


Q: Can I use Empecid if I am currently taking an antidepressant?

A: Official documentation states that the drug is an inhibitor of the CYP3A4 enzyme. This metabolic action can increase the blood levels of other medications that are broken down by this same enzyme, which includes certain types of antidepressants.


Q: Is it mentioned in the literature whether Empecid is likely to interact with grapefruit juice?

A: Official documents note that the drug inhibits the CYP3A4 enzyme. Grapefruit juice is also known to affect this same metabolic pathway, and this shared involvement of the enzyme is the basis for potential interaction concerns.


Q: Is Empecid used for pain relief in addition to its primary purpose?

A: Official documents state the primary purpose is strictly antifungal action. The drug is indicated for relieving symptoms like itching and burning that accompany the fungal infection, not as a general pain reliever for other types of pain.


Q: What are the requirements for getting a prescription for Empecid?

A: Regulatory guidance defines specific symptoms or pre-conditions (such as recurrent infections or abnormal bleeding) that are stated as reasons for a patient to consult a healthcare professional. These conditions may require prescription-level evaluation.

How should Empecid be stored and disposed of?

Storage and Disposal: Official Regulatory Information

The storage and disposal requirements for Empecid (clotrimazole) are strictly defined by regulatory documents to maintain product quality and public safety.

Requirement Area Official Instructions
Storage Temperature Store at room temperature, typically between 2 C and 30 C (36 F and 86 F) .
Prohibited Conditions The product must not be frozen and should be kept away from excess heat and moisture .
Packaging Rules Store in the original container, and keep the container, especially the tube, tightly closed after use .
Child Protection The medication must be kept strictly out of the reach of children .
Disposal Dispose of unused or expired product in accordance with local requirements . If a take-back program is unavailable, mix the medicine with an undesirable substance (e.g., used coffee grounds) and seal it in a bag before discarding in household trash .

These official statements dictate that the medication must be stored in a controlled environment to prevent degradation from temperature, light, and moisture, and must be secured to prevent access by children. Disposal must follow procedures authorized by local or national health agencies.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Empecid found in:

A-Z Index: